OBJECTIVE: To assess the association between human leukocyte antigen (HLA) haplotypes and the incidence rates of CD4 decline to < 20% and to AIDS. DESIGN: Retrospective cohort study of 95 HIV-1-infected hemophilic sibling pairs. METHODS: HLA haplotype-sharing between siblings was assigned on the basis of serologic typing of HLA class I alleles and molecular typing of HLA class II alleles. Concordance of time to CD4 decline to < 20% and to AIDS within and between sibling pairs was assessed by analysis of variance models and calculations of intraclass correlation coefficients. The age-adjusted relative risks of these two endpoints for unique class II haplotypes were determined from proportional hazards models. RESULTS: Sibling pairs sharing one or two haplotypes were significantly concordant in CD4 decline and AIDS status within 5 years of seroconversion. No concordance was found in pairs sharing zero haplotypes. At 6-10 years after seroconversion, significant concordance of these two endpoints was also observed in the pairs sharing one haplotype. The concordant results were not explained by the use of zidovudine within the pairs. Among the individuals in this cohort, the relative hazards for CD4 decline to < 20% and for AIDS were significantly elevated for one class II haplotype (DQB1*0501, DQA1*0101, DRB1*0101). In addition, the risk for AIDS was significantly increased for two other class II haplotypes (DQB1*0603, DQA1*0103, DRB1*1300, DRB3*0202 and DQB1*0301, DQA1*0501, DRB1*1400, DRB3*0202) and significantly decreased for one haplotype (DQB1*0302, DQA1*0301, DRB1*0401, DRB4*0101). CONCLUSIONS: These data demonstrate that HIV-1 disease progression is associated with the genes in the major histocompatibility complex that regulate the host's immune response.
OBJECTIVE: To assess the association between human leukocyte antigen (HLA) haplotypes and the incidence rates of CD4 decline to < 20% and to AIDS. DESIGN: Retrospective cohort study of 95 HIV-1-infected hemophilic sibling pairs. METHODS: HLA haplotype-sharing between siblings was assigned on the basis of serologic typing of HLA class I alleles and molecular typing of HLA class II alleles. Concordance of time to CD4 decline to < 20% and to AIDS within and between sibling pairs was assessed by analysis of variance models and calculations of intraclass correlation coefficients. The age-adjusted relative risks of these two endpoints for unique class II haplotypes were determined from proportional hazards models. RESULTS: Sibling pairs sharing one or two haplotypes were significantly concordant in CD4 decline and AIDS status within 5 years of seroconversion. No concordance was found in pairs sharing zero haplotypes. At 6-10 years after seroconversion, significant concordance of these two endpoints was also observed in the pairs sharing one haplotype. The concordant results were not explained by the use of zidovudine within the pairs. Among the individuals in this cohort, the relative hazards for CD4 decline to < 20% and for AIDS were significantly elevated for one class II haplotype (DQB1*0501, DQA1*0101, DRB1*0101). In addition, the risk for AIDS was significantly increased for two other class II haplotypes (DQB1*0603, DQA1*0103, DRB1*1300, DRB3*0202 and DQB1*0301, DQA1*0501, DRB1*1400, DRB3*0202) and significantly decreased for one haplotype (DQB1*0302, DQA1*0301, DRB1*0401, DRB4*0101). CONCLUSIONS: These data demonstrate that HIV-1 disease progression is associated with the genes in the major histocompatibility complex that regulate the host's immune response.
Authors: Sanjay R Mehta; Sergei L Kosakovsky Pond; Jason A Young; Douglas Richman; Susan Little; Davey M Smith Journal: J Infect Dis Date: 2012-03-23 Impact factor: 5.226
Authors: O J Cohen; M Vaccarezza; G K Lam; B F Baird; K Wildt; P M Murphy; P A Zimmerman; T B Nutman; C H Fox; S Hoover; J Adelsberger; M Baseler; J Arthos; R T Davey; R L Dewar; J Metcalf; D J Schwartzentruber; J M Orenstein; S Buchbinder; A J Saah; R Detels; J Phair; C Rinaldo; J B Margolick; G Pantaleo; A S Fauci Journal: J Clin Invest Date: 1997-09-15 Impact factor: 14.808
Authors: D T Evans; P Jing; T M Allen; D H O'Connor; H Horton; J E Venham; M Piekarczyk; J Dzuris; M Dykhuzen; J Mitchen; R A Rudersdorf; C D Pauza; A Sette; R E Bontrop; R DeMars; D I Watkins Journal: J Virol Date: 2000-08 Impact factor: 5.103
Authors: Michael W Fried; Barbara L Kroner; Liliana R Preiss; Kirk Wilhelmsen; James J Goedert Journal: Gastroenterology Date: 2006-09 Impact factor: 22.682
Authors: Ilijas Jelcic; Lilian Aly; Thomas M C Binder; Ivan Jelcic; Sílvia Bofill-Mas; Raquel Planas; Victoria Demina; Thomas H Eiermann; Thomas Weber; Rosina Girones; Mireia Sospedra; Roland Martin Journal: J Virol Date: 2013-01-09 Impact factor: 5.103
Authors: Scott A Tenenbaum; Cindy A Morris; Steve S Alexander; Harris E McFerrin; Robert F Garry; Cindy A Leissinger Journal: Virol J Date: 2005-08-17 Impact factor: 4.099